Risk of Nerve Damage After Administration of Local Anesthesia

Risk of Nerve Damage After Administration of an Inferior Alveolar Nerve Block Using 4% Articaine Versus 2% Lidocaine

This research aims to evaluate of the risk of nerve damage following the administration of articaine 4% and lidocaine 2% for Inferior Alveolar nerve Block (IANB). A Randomized Controlled Clinical Trial will be conducted where the patient will be randomly assigned to one the two groups; articaine 4% and Lidocaine 2%. The type of LA will be concealed to the operator, investigators and assessors. The patients will be monitored for any aigns of nerve parathesia for 3 months after the procedure.

Inclusion Criteria:

• Patients with age between 18-55 years old
• Patients need IANB
• healthy patient

Exclusion Criteria:

• medical conditions
• allergies
• medications
• pregnancy and breastfeeding
• inability to provide informed consent
• specific dental or medical history.